1 Disease Control and Prevention Vaccine Market Overview 1.1 Product Overview and Scope of Disease Control and Prevention Vaccine 1.2 Disease Control and Prevention Vaccine Segment by Type 1.2.1 Global Disease Control and Prevention Vaccine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Live-Attenuated 1.2.3 Inactivated 1.2.4 Recombinant Sub Unit and Toxoid 1.3 Disease Control and Prevention Vaccine Segment by Application 1.3.1 Global Disease Control and Prevention Vaccine Sales Comparison by Application: (2021-2027) 1.3.2 Pediatric Vaccine 1.3.3 Adult Vaccine 1.4 Global Disease Control and Prevention Vaccine Market Size Estimates and Forecasts 1.4.1 Global Disease Control and Prevention Vaccine Revenue 2016-2027 1.4.2 Global Disease Control and Prevention Vaccine Sales 2016-2027 1.4.3 Disease Control and Prevention Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Disease Control and Prevention Vaccine Market Competition by Manufacturers 2.1 Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Disease Control and Prevention Vaccine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Disease Control and Prevention Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Disease Control and Prevention Vaccine Market Competitive Situation and Trends 2.5.1 Disease Control and Prevention Vaccine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Disease Control and Prevention Vaccine Players Market Share by Revenue 2.5.3 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Disease Control and Prevention Vaccine Retrospective Market Scenario by Region 3.1 Global Disease Control and Prevention Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Disease Control and Prevention Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.3.1 North America Disease Control and Prevention Vaccine Sales by Country 3.3.2 North America Disease Control and Prevention Vaccine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.4.1 Europe Disease Control and Prevention Vaccine Sales by Country 3.4.2 Europe Disease Control and Prevention Vaccine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Disease Control and Prevention Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Region 3.5.2 Asia Pacific Disease Control and Prevention Vaccine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.6.1 Latin America Disease Control and Prevention Vaccine Sales by Country 3.6.2 Latin America Disease Control and Prevention Vaccine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Country 3.7.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Disease Control and Prevention Vaccine Historic Market Analysis by Type 4.1 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021) 4.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2016-2021) 4.3 Global Disease Control and Prevention Vaccine Price by Type (2016-2021) 5 Global Disease Control and Prevention Vaccine Historic Market Analysis by Application 5.1 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021) 5.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2016-2021) 5.3 Global Disease Control and Prevention Vaccine Price by Application (2016-2021) 6 Key Companies Profiled 6.1 GSK 6.1.1 GSK Corporation Information 6.1.2 GSK Description and Business Overview 6.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 GSK Disease Control and Prevention Vaccine Product Portfolio 6.1.5 GSK Recent Developments/Updates 6.2 Merck & Co., Inc 6.2.1 Merck & Co., Inc Corporation Information 6.2.2 Merck & Co., Inc Description and Business Overview 6.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio 6.2.5 Merck & Co., Inc Recent Developments/Updates 6.3 Pfizer 6.3.1 Pfizer Corporation Information 6.3.2 Pfizer Description and Business Overview 6.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Pfizer Disease Control and Prevention Vaccine Product Portfolio 6.3.5 Pfizer Recent Developments/Updates 6.4 Sanofi 6.4.1 Sanofi Corporation Information 6.4.2 Sanofi Description and Business Overview 6.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi Disease Control and Prevention Vaccine Product Portfolio 6.4.5 Sanofi Recent Developments/Updates 6.5 AstraZeneca PLC 6.5.1 AstraZeneca PLC Corporation Information 6.5.2 AstraZeneca PLC Description and Business Overview 6.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio 6.5.5 AstraZeneca PLC Recent Developments/Updates 6.6 Sinovac Biotech Ltd 6.6.1 Sinovac Biotech Ltd Corporation Information 6.6.2 Sinovac Biotech Ltd Description and Business Overview 6.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio 6.6.5 Sinovac Biotech Ltd Recent Developments/Updates 6.7 Astellas Pharma Inc 6.6.1 Astellas Pharma Inc Corporation Information 6.6.2 Astellas Pharma Inc Description and Business Overview 6.6.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio 6.7.5 Astellas Pharma Inc Recent Developments/Updates 6.8 Serum Institute of India Pvt. Ltd 6.8.1 Serum Institute of India Pvt. Ltd Corporation Information 6.8.2 Serum Institute of India Pvt. Ltd Description and Business Overview 6.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio 6.8.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates 6.9 Daiichi Sankyo 6.9.1 Daiichi Sankyo Corporation Information 6.9.2 Daiichi Sankyo Description and Business Overview 6.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio 6.9.5 Daiichi Sankyo Recent Developments/Updates 7 Disease Control and Prevention Vaccine Manufacturing Cost Analysis 7.1 Disease Control and Prevention Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Disease Control and Prevention Vaccine 7.4 Disease Control and Prevention Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Disease Control and Prevention Vaccine Distributors List 8.3 Disease Control and Prevention Vaccine Customers 9 Disease Control and Prevention Vaccine Market Dynamics 9.1 Disease Control and Prevention Vaccine Industry Trends 9.2 Disease Control and Prevention Vaccine Growth Drivers 9.3 Disease Control and Prevention Vaccine Market Challenges 9.4 Disease Control and Prevention Vaccine Market Restraints 10 Global Market Forecast 10.1 Disease Control and Prevention Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Disease Control and Prevention Vaccine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Disease Control and Prevention Vaccine by Type (2022-2027) 10.2 Disease Control and Prevention Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Disease Control and Prevention Vaccine by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Disease Control and Prevention Vaccine by Application (2022-2027) 10.3 Disease Control and Prevention Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Disease Control and Prevention Vaccine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Disease Control and Prevention Vaccine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Disease Control and Prevention Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Disease Control and Prevention Vaccine Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Disease Control and Prevention Vaccine Covered in This Study Table 5. Global Disease Control and Prevention Vaccine Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturers (2016-2021) Table 7. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Disease Control and Prevention Vaccine Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Disease Control and Prevention Vaccine Manufacturing Sites and Area Served Table 11. Manufacturers Disease Control and Prevention Vaccine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Disease Control and Prevention Vaccine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Disease Control and Prevention Vaccine Sales by Region (2016-2021) & (K Units) Table 16. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2021) Table 17. Global Disease Control and Prevention Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Disease Control and Prevention Vaccine Sales by Country (2016-2021) & (K Units) Table 19. North America Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2021) Table 20. North America Disease Control and Prevention Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2021) Table 22. Europe Disease Control and Prevention Vaccine Sales by Country (2016-2021) & (K Units) Table 23. Europe Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2021) Table 24. Europe Disease Control and Prevention Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Disease Control and Prevention Vaccine Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Disease Control and Prevention Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Region (2016-2021) Table 30. Latin America Disease Control and Prevention Vaccine Sales by Country (2016-2021) & (K Units) Table 31. Latin America Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2021) Table 32. Latin America Disease Control and Prevention Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2021) Table 38. Global Disease Control and Prevention Vaccine Sales (K Units) by Type (2016-2021) Table 39. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021) Table 40. Global Disease Control and Prevention Vaccine Revenue (Million US$) by Type (2016-2021) Table 41. Global Disease Control and Prevention Vaccine Revenue Share by Type (2016-2021) Table 42. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Type (2016-2021) Table 43. Global Disease Control and Prevention Vaccine Sales (K Units) by Application (2016-2021) Table 44. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021) Table 45. Global Disease Control and Prevention Vaccine Revenue (Million US$) by Application (2016-2021) Table 46. Global Disease Control and Prevention Vaccine Revenue Share by Application (2016-2021) Table 47. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Application (2016-2021) Table 48. GSK Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. GSK Disease Control and Prevention Vaccine Product Table 52. GSK Recent Developments/Updates Table 53. Merck & Co., Inc Corporation Information Table 54. Merck & Co., Inc Description and Business Overview Table 55. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Merck & Co., Inc Disease Control and Prevention Vaccine Product Table 57. Merck & Co., Inc Recent Developments/Updates Table 58. Pfizer Corporation Information Table 59. Pfizer Description and Business Overview Table 60. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Pfizer Disease Control and Prevention Vaccine Product Table 62. Pfizer Recent Developments/Updates Table 63. Sanofi Corporation Information Table 64. Sanofi Description and Business Overview Table 65. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Sanofi Disease Control and Prevention Vaccine Product Table 67. Sanofi Recent Developments/Updates Table 68. AstraZeneca PLC Corporation Information Table 69. AstraZeneca PLC Description and Business Overview Table 70. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. AstraZeneca PLC Disease Control and Prevention Vaccine Product Table 72. AstraZeneca PLC Recent Developments/Updates Table 73. Sinovac Biotech Ltd Corporation Information Table 74. Sinovac Biotech Ltd Description and Business Overview Table 75. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Table 77. Sinovac Biotech Ltd Recent Developments/Updates Table 78. Astellas Pharma Inc Corporation Information Table 79. Astellas Pharma Inc Description and Business Overview Table 80. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Table 82. Astellas Pharma Inc Recent Developments/Updates Table 83. Serum Institute of India Pvt. Ltd Corporation Information Table 84. Serum Institute of India Pvt. Ltd Description and Business Overview Table 85. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Table 87. Serum Institute of India Pvt. Ltd Recent Developments/Updates Table 88. Daiichi Sankyo Corporation Information Table 89. Daiichi Sankyo Description and Business Overview Table 90. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Daiichi Sankyo Disease Control and Prevention Vaccine Product Table 92. Daiichi Sankyo Recent Developments/Updates Table 93. Production Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Disease Control and Prevention Vaccine Distributors List Table 96. Disease Control and Prevention Vaccine Customers List Table 97. Disease Control and Prevention Vaccine Market Trends Table 98. Disease Control and Prevention Vaccine Growth Drivers Table 99. Disease Control and Prevention Vaccine Market Challenges Table 100. Disease Control and Prevention Vaccine Market Restraints Table 101. Global Disease Control and Prevention Vaccine Sales Forecast by Type (2022-2027) & (K Units) Table 102. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Type (2022-2027) Table 103. Global Disease Control and Prevention Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 104. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 105. Global Disease Control and Prevention Vaccine Sales Forecast by Application (2022-2027) & (K Units) Table 106. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Application (2022-2027) Table 107. Global Disease Control and Prevention Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 108. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Application (2022-2027) Table 109. Global Disease Control and Prevention Vaccine Sales Forecast by Region (2022-2027) & (K Units) Table 110. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Region (2022-2027) Table 111. Global Disease Control and Prevention Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 112. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Disease Control and Prevention Vaccine Figure 2. Global Disease Control and Prevention Vaccine Market Share by Type in 2020 & 2027 Figure 3. Live-Attenuated Product Picture Figure 4. Inactivated Product Picture Figure 5. Recombinant Sub Unit and Toxoid Product Picture Figure 6. Global Disease Control and Prevention Vaccine Market Share by Application in 2020 & 2027 Figure 7. Pediatric Vaccine Figure 8. Adult Vaccine Figure 9. Global Disease Control and Prevention Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Disease Control and Prevention Vaccine Market Size 2016-2027 (US$ Million) Figure 11. Global Disease Control and Prevention Vaccine Sales 2016-2027 (K Units) Figure 12. Global Disease Control and Prevention Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Disease Control and Prevention Vaccine Sales Share by Manufacturers in 2020 Figure 14. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Disease Control and Prevention Vaccine Players: Market Share by Revenue in 2020 Figure 16. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2021) Figure 18. Global Disease Control and Prevention Vaccine Sales Market Share by Region in 2020 Figure 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2016-2021) Figure 20. Global Disease Control and Prevention Vaccine Revenue Market Share by Region in 2020 Figure 21. U.S. Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Disease Control and Prevention Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Disease Control and Prevention Vaccine by Type (2016-2021) Figure 46. Sales Market Share of Disease Control and Prevention Vaccine by Application (2016-2021) Figure 47. Sales Market Share of Disease Control and Prevention Vaccine by Application in 2020 Figure 48. Revenue Share of Disease Control and Prevention Vaccine by Application (2016-2021) Figure 49. Revenue Share of Disease Control and Prevention Vaccine by Application in 2020 Figure 50. Manufacturing Cost Structure of Disease Control and Prevention Vaccine Figure 51. Manufacturing Process Analysis of Disease Control and Prevention Vaccine Figure 52. Disease Control and Prevention Vaccine Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

GSK Merck & Co., Inc Pfizer Sanofi AstraZeneca PLC Sinovac Biotech Ltd Astellas Pharma Inc Serum Institute of India Pvt. Ltd Daiichi Sankyo